Understanding difficult-to-treat diseases such as diabetes and cancer and turning that knowledge into new diagnostics and treatments takes more than one laboratory, company, or field of expertise.

Basic medicine, life sciences, hematopoietic stem cells, cell targeting, informatics, AI, robotics, public health, clinical development, and international business development: connecting these fields can turn research findings into greater value for society.

Through collaborations with universities, research institutions, companies, and technology organizations in Japan and abroad, Biozipcode, Inc. is building a research and development network that connects basic research with human validation, technology development, local implementation, and international expansion.

At the academic core of Biozipcode, Inc.’s research and development is its collaboration with the joint industry–academia department at Kyoto University’s Graduate School of Medicine and Faculty of Medicine, the “Department of Biocommunication Development”.

Since April 2026, the partners have pursued the research theme “Development of Cell-Targeted Therapy”, studying diabetes stem cells (DSCs, a research term), Biozipcode™, cancer, tissue regeneration, and difficult-to-treat diseases. Biozipcode, Inc. participates as a corporate research collaborator, helping turn university findings into intellectual property, diagnostic and therapeutic technologies, and joint development projects.

Main Areas of Collaboration

Diabetes stem cells / Biozipcode™ / cell targeting / research into complete diabetes remission / cancer / tissue regeneration / human disease research / bioinformatics

By combining scientific discovery and validation at the university with industry development, we aim to bring basic research closer to care that reaches patients.

Studio Makyu Co., Ltd. has long helped build the research infrastructure of Biozipcode, Inc., supporting technology development that connects life sciences and informatics.

Life science research needs a computational foundation to analyze the vast amounts of sequence and biological data generated by experiments and turn them into reproducible findings.

Alongside software and hardware development, Studio Makyu lists drug design and bioinformatics among its business areas.

In its collaboration with Biozipcode, Inc., the company combines experiments, sequence analysis, software, and high-performance computing to build an informatics platform supporting research into Biozipcode™ and other areas.

Main Areas of Collaboration

Bioinformatics / NGS and sequence analysis / research software / high-performance computing / GPGPU / AI and data analysis / Biozipcode™ analysis platform

Connecting wet biology and computational science to uncover new biological insights from experimental data.

Life science research is moving toward physical AI, which connects information analysis with the physical world of laboratory instruments, robots, and sensors.

Through its collaboration with Cranfield Japan Centre, Biozipcode, Inc. is exploring a next-generation research platform that brings together life sciences and advanced technologies such as AI, robotics, and research automation.

Cranfield Japan Centre has a history in robotics and AI and now aims to establish an advanced technology research institution and industry cluster encompassing aerospace.

Looking ahead, we aim to combine biological information obtained through Biozipcode™ and related research with AI and robotics to build a research environment that cycles through analysis → decision-making → experimentation → evaluation.

Main Areas of Collaboration

Physical AI / AI / robotics / research automation / sensors / laboratory equipment integration / advanced technology / industry–academia collaboration

Moving from AI that analyzes biological information to AI that acts in the research environment.

Biozipcode, Inc. is also building a research and public health network in the Republic of Palau to connect research findings with local communities.

Palau Community College (PCC) is one of its key partners.

PCC offers a Community & Public Health program that covers epidemiology, health promotion, noncommunicable diseases, and public health information. Its Cooperative Research & Extension program works with community partners to conduct research and share knowledge on food and nutrition, human sciences, and the environment.

Through its collaboration with PCC, Biozipcode, Inc. aims to build a network for research into diabetes and other metabolic diseases, public health, training, health data, and the local application of research findings.

Main Areas of Collaboration

Diabetes and metabolic diseases / public health / noncommunicable diseases / community health research / health data / research support / training / practical application

Connecting research findings with communities and people beyond the laboratory.

Bringing research findings to healthcare around the world requires collaboration not only in research and development but also with businesses, healthcare providers, public agencies, and industry networks rooted in each region.

Biozipcode, Inc. is working with Dubai-based KHOORY & PARK L.L.C to develop a partner network and international business opportunities in the Middle East.

KHOORY & PARK L.L.C works in international sales and business development, consulting, and general trading, and has built networks connecting Japanese and Korean companies with the Middle East. Its public materials also describe a partnership with the Korean biotechnology company Macrogen related to the UAE Genome Project.

Through this network, Biozipcode, Inc. aims to expand ties with local companies, research institutions, and healthcare organizations in life sciences and medicine, with a view to future joint development and the introduction of research findings in the Middle East.

Main Areas of Collaboration

UAE and Middle East networks / international business development / healthcare and biotech partnerships / local collaboration / international application of research findings

Connecting scientific findings with regional networks to bring research beyond borders and into society.